Foley Presents our Fifth Annual Study on the Costs of Corporate Governance
02 August 2007
Since the signing of the Sarbanes-Oxley Act, Foley has followed the impact its reforms have had on corporate America. Over the years, these studies have been cited by academia and government and business leaders around the world, as well as by the media.
Following are several ways to access the results of our 2007 study:
The Cost of Being Public in the Era of Sarbanes-Oxley
Download the 2007 study The Cost of Being Public in the Era of Sarbanes-Oxley.
View the press release.
View and listen to a recorded Web conference on the study results.
For more information on Foley’s studies, please contact Jocelyn Brumbaugh at [email protected].
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.